NCT02962622

Brief Summary

The study evaluates the association between soluble insulin receptor dysfunction, cardiorespiratory fitness, and HIV associated neurocognitive disorder (HAND). Those who volunteer to participate in the study will have two evaluations at study entry that include a dual x-ray absorptiometry (DEXA) densitometry, anthropometry, neurocognitive testing, blood and urine samples for metabolic testing, and a cardiorespiratory fitness testing. DEXA will be conducted in the Endocrinology Unit at the University Hospital, Medical Center (letter of support included). The cardiorespiratory fitness testing will be conducted in the AIDS Clinical Trials Unit (ACTU) project, University of Puerto Rico, Medical Sciences Campus, and the Puerto Rico Clinical and Translational Research Consortium. Then, participants will be invited to participate in a 6-week, 3 days/week individualized exercise program. The exercise program will be conducted at the University of Puerto Rico Medical Sciences Campus. After completion of the exercise program, study entry evaluations will be repeated. The duration of the study will take approximately 10 weeks.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at below P25 for not_applicable hiv

Timeline
Completed

Started Nov 2014

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 5, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

November 11, 2016

Status Verified

November 1, 2016

Enrollment Period

2.6 years

First QC Date

October 5, 2016

Last Update Submit

November 9, 2016

Conditions

Keywords

NeurocognitionExerciseMetabolismHispanic women

Outcome Measures

Primary Outcomes (1)

  • Cardio-respiratory fitness as measured by maximal oxygen consumption (VO2max)

    Maximal oxygen consumption

    6 weeks

Secondary Outcomes (2)

  • Metabolic syndrome classification based on the National Cholesterol Education Program (NCEP) criteria

    6 weeks

  • Neurocognitive function as measured by memory testing

    6 weeks

Study Arms (2)

Hispanic women living with HIV

EXPERIMENTAL

High intensity interval training (HIIT) on normally active but physically untrained HIV+ Hispanic women, one with (n=15) and other without (n=15) neuro-cognitive impairment (HAND) on antiretroviral therapy (CART) receive 2 weeks, 6 sessions of 8 x 60 seconds cycling bouts eliciting approximately 80% of maximal heart rate with 60 second rest between bouts after which they will receive 4 week, 12 sessions of 10 x 60 seconds cycling bouts eliciting approximately 90% of maximal heart rate with 60 second rest between bouts.

Other: High intensity interval training (HIIT)

Hispanic women living without HIV

EXPERIMENTAL

High intensity interval training (HIIT) on a comparison group of 15 Hispanic women without HIV receive 2 weeks, 6 sessions of 8 x 60 seconds cycling bouts eliciting approximately 80% of maximal heart rate with 60 second rest between bouts after which they will receive 4 week, 12 sessions of 10 x 60 seconds cycling bouts eliciting approximately 90% of maximal heart rate with 60 second rest between bouts.

Other: High intensity interval training (HIIT)

Interventions

Six weeks, three days per week (total of 18 sessions) of HIIT cycle ergometer exercise protocol

Hispanic women living with HIVHispanic women living without HIV

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-seropositive women ≥21 years with lymphocytes differentiated cells 4 (CD4) cell count or nadir in the last year ≤500 cells/mm3, or viral load ≥1,000 copies/mL despite highly active antiretroviral therapy (HAART).
  • Education level ≥9th grade, since is the minimum required for some of the neuro-psychological (NP) tests. All HIV-seropositive and HIV-seronegative participants will be tested for vocabulary and reading pre-morbid cognitive function as described below.
  • Non-drug abusers; defined as those with \<5 exposures in a lifetime to drugs (opiates/heroin, methamphetamine, cocaine/crack, speed ball). For the purpose of this study neither tobacco nor nicotine use will be considered a drug.
  • No diagnosis of diabetes or the use of hypoglycemic agents.

You may not qualify if:

  • HIV+ women and men \<21 years old with CD4 cell count \>500 cells/mm3 and/or viral load \<1,000 copies/mL.
  • Opportunistic infections of the central nervous system (CNS) as determined by neurological evaluation and neuroimaging. (Neuroimaging studies, if needed, will be performed as part of patient care and hence have not been included as a budget item in this proposal.)
  • History of diabetes or the use hypoglycemic agents.
  • Underlying neurologic and/or neuropsychiatric disorders such as cerebrovascular events; history of meningitis/encephalitis, CNS opportunistic infections, or seizures; head trauma (\<6 months with loss of consciousness for \>1 hr); cerebral palsy; or any other neuropsychiatric condition that in the judgment of the investigators may affect the study.
  • Active systemic infection or illness, which in the judgment of the investigators may affect the study.
  • Pregnant/nursing mothers or women with recent birth (\<60 days).
  • Substance abuse: active drug use - all participants will be screened with urine toxicology and active alcohol abuse - those scoring \>3 points in the Michigan Alcoholism Screening Test (MAST) will be screened with blood samples for alcohol levels (Seltzer 1975).
  • Patients who are unwilling to give informed consent or incapable of understanding informed consent.
  • Education less than 9th grade.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Sciences Campus

San Juan, 00936, Puerto Rico

RECRUITING

Related Publications (1)

  • Ramirez-Marrero FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, Santana-Bagur J, Frontera WR, Wojna V. Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study. J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):285-289. doi: 10.1097/QAI.0000000000002353.

MeSH Terms

Conditions

Motor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Farah A. Ramirez-Marrero, PhD

    University of Puerto Rico

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Farah A. Ramirez-Marrero, PhD

CONTACT

Valerie Wojna-Muniz, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 5, 2016

First Posted

November 11, 2016

Study Start

November 1, 2014

Primary Completion

June 1, 2017

Study Completion

December 1, 2017

Last Updated

November 11, 2016

Record last verified: 2016-11

Locations